Advanced Prostate Cancer Consensus Conference (APCCC)
In advanced prostate cancer, rapid and successful drug development has resulted in multiple treatment options that require careful decision-making for individual patients. Clinicians face the increasingly difficult task of choosing from multiple potentially effective treatments that also are costly and potentially toxic. Further developments in novel next-generation imaging methods, biomarkers, ...
read more ↘
read more ↘
Videos
Advanced Prostate Cancer Consensus Conference (APCCC)
Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC
FEATURING
Karim Fizazi
- 39 views
- November 19, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Managing Side Effects of PARP Inhibitors in mCRPC
FEATURING
Elena Castro
- 15 views
- November 12, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Optimizing Escalation Strategies for mHSPC With Unfavorable PSA Declines
FEATURING
Mary-Ellen Taplin
- 4 views
- November 11, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Managing mHSPC With Early Progression on Combination Therapy
FEATURING
Christopher Sweeney
- 3 views
- November 11, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Guidelines for Tumor Genomic Profiling in Advanced Prostate Cancer
FEATURING
Niven Mehra
- 26 views
- November 8, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Best Use of PARP Inhibitors in mCRPC With BRCA1/2 Alterations
FEATURING
Joaquin Mateo
- 12 views
- November 5, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
PARP Inhibition (Dissected): Determining Who Benefits in mCRPC
FEATURING
Johann de Bono
- 22 views
- November 5, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Future Changes in the Setting of mHSPC
FEATURING
Gerhardt Attard
- 31 views
- November 4, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Recommended Imaging Standards for mHSPC in Daily Practice
FEATURING
Michael Morris
- 33 views
- November 4, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Relevant Prognostic and Predictive Factors in mHSPC
FEATURING
Matthew Smith
- 30 views
- October 30, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Management of Frail Patients With mHSPC
FEATURING
Maria De Santis
- 30 views
- October 25, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Total Therapy Considerations in Low-Volume mHSPC: Intensification vs. De-Intensification
FEATURING
Oliver Sartor
- 90 views
- October 23, 2024
- 4